KURA   $11.16  -0.27% Market Open

Kura Oncology Inc
Total Cash 491.52M
totalCashPerShare 6.414
EBITDA -199.22M
Total Debt 16.73M
quickRatio 14.834
currentRatio 14.94
Total Revenue
debtToEquity 3.59
Revenue/Share
ROA -0.24767
ROE -0.39266
grossProfits
freeCashflow -84.13M
operatingCashflow -154.71M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 867.85M
forwardPE -6.8091607
floatShares 49.09M
sharesOutstanding 76.63M
sharesShort 9.29M
sharesShortPriorMonth 10.75M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.07%
Short Ratio help_outline 18.16%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 6.099
Price To Book help_outline 2.93
earningsQuarterlyGrowth
netIncomeToCommon -181.75M
trailingEps -2.23%
forwardEps -2.62%
enterpriseToEbitda -4.36
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.63 3Q 2024
institutionsCount 248
lastUpdated Nov. 7, 2024, 2:23 a.m.